Articles related to Multiple Myeloma-Plasma Cell Cancer
New Study Finds "Off the Shelf CAR-T" Promising for Certain Lymphoma Patients
Moffitt is one of a few hospitals nationwide testing ALLO-501a, an allogeneic CAR T therapy product from Allogene Therapeutics, in combination with ALLO-64 Read More
Comprehensive Molecular Profiling of Undifferentiated Embryonal Sarcoma of the Liver
Moffitt Cancer Center is leading the research in rare sarcomas and has performed the most comprehensive molecular analysis to-date of undifferentiated embryonal sarcoma of the liver Read More
Reshaping the Frontline Treatment Landscape of ES-SCLC
Dr. Bruna Pellini, in an interview with OncLive®, also compares the findings of the CASPIAN and IMpower133 trials and research efforts currently ongoing in ES-SCLC Read More
Improving Representation of Racial and Ethnic Minorities in Lung Cancer Screening Programs
With recent screening guidelines changes, more people are eligible for a low-dose CT scan and have the ability to participate in lung screening programs or trials. Read More
CAR T Clinical Trials for Multiple Myeloma Bring Promising New Treatments
Moffitt researchers are leaders in advancing the field of CAR T therapy and multiple myeloma clinical trials provide patients with exciting new treatment opportunities. Read More
March Is Multiple Myeloma Awareness and Action Month
Exactly what is multiple myeloma? Even though it is the second most common form of blood cancer, many people have never heard of it. Read More
